Immutep IMMP
NASDAQ IMMP
$0.36 -0.01 (-2.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Immutep (IMMP) Non Operating Interest Expenses (2011 - 2015)

Immutep's (IMMP) quarterly Non Operating Interest Expenses came in at -$205.0 in Q2 2015, up 100.0% on a YoY basis from -$102.5 in Q2 2014, and up 100.0% quarter-over-quarter from -$12.0 million in Q2 2014.

Analysis

Immutep (IMMP) Non Operating Interest Expenses (2011 - 2015) Analysis & Trends

Immutep (IMMP) has reported Non Operating Interest Expenses for 4 consecutive years, with -$205.0 the latest figure, recorded in Q2 2015.

  • For the quarter ending Q2 2015, Non Operating Interest Expenses rose 100.0% year-over-year to -$205.0; the trailing twelve-month figure through Jun 2016 stood at -$26.8 million (up 45.43% YoY), and the FY2026 full-year result was -$48162.3, down 102.82% from the prior year.
  • Non Operating Interest Expenses rose to -$205.0 in Q2 2015 per IMMP's latest filing, from -$12.0 million in the prior quarter.
  • Across five years, Non Operating Interest Expenses topped out at -$205.0 in Q2 2015 and bottomed at -$22.3 million in Q2 2011.
  • Historically, Non Operating Interest Expenses has averaged -$12.3 million across 4 years, with a median of -$13.4 million in 2013.
  • The sharpest annual moves came in 2014 and 2015: Non Operating Interest Expenses gained 18.76% in 2014, then soared 100.0% in 2015.
  • Over 4 years, Non Operating Interest Expenses stood at -$22.3 million in 2011, then jumped by 33.73% to -$14.8 million in 2013, then grew by 18.76% to -$12.0 million in 2014, then jumped by 100.0% to -$205.0 in 2015.
  • According to Business Quant data, Non Operating Interest Expenses over the past three periods registered -$205.0, -$12.0 million, and -$14.8 million for Q2 2015, Q2 2014, and Q2 2013 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Immutep 51.68 Mn 51.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 -205.00
Jun 30, 2014 -12.01 Mn
Jun 30, 2013 -14.79 Mn
Jun 30, 2011 -22.31 Mn